CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 151 enrolled
Drug / intervention
Probiotics +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01445704
NCT01445704N/ACompleted
CompareCT.gov

Use of Probiotics to Aid in Weight Loss

Prisma Health-Upstate·interventional·Posted Oct 4, 2011·Updated Apr 9, 2014

In Brief

A clinical study evaluating Probiotics and Placebo for Weight Loss. Completed, enrolled 151 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the success of daily supplementation of multiple probiotic bacterial cultures over 12 weeks in increasing the percentage of excess weight loss in the RNYGB (Gastric Bypass) weight loss population.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWeight Loss
CountriesUnited States
CollaboratorsXymogen, Inc.

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 4, 2011
Enrollment StartJun 1, 2010
Primary CompletionJan 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 14.7 years ago

Interventions

Probioticsdietary

The probiotic supplementation will use lactic acid bacteria in the "ProbioMax DF™" supplement from Xymogen, Inc. This preparation consists of a four-strain probiotic with 100 billion CFU per vegetable capsule. The strains included are Lactobacillus acidophilus La-14, Bifidobacterium lactis HN019, Lactobacillus planarum Lp-115, and Bifidobacterium longum B1-05.

Placebodietary

The placebo supplementation is identical-looking to the capsule of the probiotic supplementation.